Proctitis

Proctitis is the inflammation of the rectum, the terminal portion of the large intestine, which extends from the descending colon to the anus. It is a specific form of inflammatory bowel disease (IBD) that can occur in dogs and cats, often as part of a more diffuse colonic inflammation (colitis) or as an isolated condition. The rectum is responsible for the storage and expulsion of feces, and its inflammation leads to clinical signs such as tenesmus, dyschezia, hematochezia, and increased frequency of defecation. Proctitis can be classified based on the underlying cause (e.g., infectious, inflammatory, neoplastic, traumatic) and the chronicity (acute vs. chronic). It is a common clinical presentation in small animal practice, and its management requires a thorough diagnostic workup to identify the etiopathogenesis and to guide targeted therapy.

The etiology of proctitis is multifactorial and includes infectious agents, inflammatory conditions, trauma, and neoplasia. Infectious causes include bacterial pathogens such as Salmonella spp., Campylobacter spp., Clostridium difficile, and Escherichia coli (especially adherent-invasive strains). Viral agents such as canine parvovirus (CPV) and feline panleukopenia virus can cause severe hemorrhagic proctitis. Parasitic infections, particularly with Trichuris vulpis (whipworm) in dogs and Tritrichomonas foetus in cats, are significant causes. Fungal infections, such as histoplasmosis (Histoplasma capsulatum) and pythiosis (Pythium insidiosum), can also affect the rectum. Inflammatory causes include idiopathic inflammatory bowel disease (IBD), which encompasses lymphocytic-plasmacytic, eosinophilic, and granulomatous colitis. Eosinophilic proctitis may be associated with food allergies or parasitic infections. Traumatic causes include foreign body ingestion, perianal fistulas, and iatrogenic injury from enemas or rectal examinations. Neoplastic conditions such as adenocarcinoma, lymphoma, and leiomyosarcoma can cause secondary inflammation. Additionally, metabolic and endocrine disorders, such as hypothyroidism, can predispose to chronic inflammation. In some cases, the exact cause remains unknown, and the condition is termed idiopathic proctitis.

Proctitis is a common condition in both dogs and cats, though the exact incidence is not well-documented. In dogs, certain breeds such as Boxers, French Bulldogs, and German Shepherds may have a higher predisposition to inflammatory bowel disease, including proctitis. Age of onset varies; IBD is often diagnosed in middle-aged to older animals, while infectious proctitis can occur at any age, particularly in young animals or those with compromised immune systems. Cats, especially those with chronic diarrhea, may develop proctitis secondary to Tritrichomonas foetus infection, which is more common in young cats from multi-cat environments. Geographic distribution influences the prevalence of fungal causes; for example, histoplasmosis is more common in the Ohio and Mississippi River valleys, while pythiosis is seen in tropical and subtropical regions. There is no strong sex predilection, though some studies suggest a slight male predominance in certain neoplastic conditions. Environmental factors such as poor sanitation, overcrowding, and stress can increase the risk of infectious proctitis.

The pathophysiology of proctitis involves disruption of the mucosal barrier, leading to inflammation and ulceration. In infectious proctitis, pathogens adhere to and invade the epithelial cells, triggering an innate immune response with release of pro-inflammatory cytokines (e.g., TNF-α, IL-1β, IL-6). This leads to recruitment of neutrophils and macrophages, causing tissue damage and necrosis. In IBD, the pathogenesis is thought to involve a dysregulated immune response to commensal bacteria in genetically susceptible individuals, resulting in chronic inflammation. Lymphocytic-plasmacytic infiltration is the most common histologic finding, but eosinophilic infiltration may occur in response to allergens or parasites. The inflammation disrupts normal water and electrolyte absorption, leading to diarrhea. In the rectum, the inflammation stimulates stretch receptors, causing tenesmus and increased frequency of defecation. Chronic inflammation can lead to fibrosis, stricture formation, and loss of mucosal architecture. In neoplastic conditions, tumor growth can cause mechanical obstruction and secondary inflammation. Systemic effects may include protein-losing enteropathy, weight loss, and anemia from chronic blood loss.

Predisposing factors for proctitis include genetic susceptibility, as seen in breeds with a higher incidence of IBD (e.g., Boxers, French Bulldogs). Age is a factor; young animals are more susceptible to infectious causes, while older animals are at higher risk for neoplasia. Immunosuppression, whether due to stress, concurrent disease (e.g., feline leukemia virus, feline immunodeficiency virus), or drug therapy (e.g., corticosteroids), increases the risk of infectious proctitis. Dietary factors, such as food allergies or intolerance, can trigger eosinophilic proctitis. Poor hygiene and overcrowding facilitate the spread of infectious agents. Chronic constipation or obstipation can lead to rectal irritation and inflammation. Previous gastrointestinal surgery or trauma may predispose to strictures and secondary proctitis. Additionally, certain medications, such as non-steroidal anti-inflammatory drugs (NSAIDs), can cause mucosal damage and exacerbate inflammation.

Clinical signs of proctitis are primarily related to defecation. The most common signs include tenesmus (straining to defecate), dyschezia (painful defecation), hematochezia (fresh blood in feces), and increased frequency of defecation with small volumes of feces. Mucus may be present in the stool. Animals may exhibit perineal discomfort, licking of the perianal area, and scooting. In acute severe cases, systemic signs such as lethargy, fever, and anorexia may be present, especially if the cause is infectious. Chronic proctitis may lead to weight loss, poor body condition, and signs of protein-losing enteropathy (e.g., edema, ascites). On physical examination, palpation of the rectum may elicit pain, and the rectal mucosa may feel thickened or irregular. In cases of perianal fistulas, there may be draining tracts and ulceration around the anus. Neoplastic causes may present with a palpable mass or stricture on rectal palpation. In cats with Tritrichomonas foetus infection, chronic large-bowel diarrhea with mucus and blood is common, and the condition may be mistaken for IBD.

Differential diagnoses for proctitis include: 1) Colitis (inflammation of the colon) – often presents with similar signs, but proctitis is localized to the rectum; colonoscopy can differentiate. 2) Perianal fistula – characterized by chronic, painful ulcerating tracts in the perianal region, often in German Shepherds; distinct on physical exam. 3) Rectal polyps – benign growths that can cause tenesmus and hematochezia; identified on rectal palpation or endoscopy. 4) Rectal adenocarcinoma – malignant tumor, often presents with progressive tenesmus and weight loss; biopsy confirms. 5) Anal sac disease – impaction or infection of anal sacs, causing perineal pain and scooting; palpation of anal sacs reveals abnormalities. 6) Foreign body – ingestion of bones or other sharp objects can cause rectal trauma and inflammation; history and imaging may reveal. 7) Clostridial colitis – caused by Clostridium perfringens, often associated with acute diarrhea and hematochezia; fecal toxin assays can help. 8) Parasitic infections (e.g., whipworms) – can cause large-bowel diarrhea and proctitis; fecal flotation is diagnostic. 9) Inflammatory bowel disease (IBD) – may involve the rectum, but typically affects other parts of the GI tract; histopathology is needed. 10) Rectal stricture – can be a sequela of chronic inflammation or trauma; imaging and endoscopy reveal narrowing.

The diagnostic approach to proctitis begins with a thorough history and physical examination, including digital rectal palpation. If proctitis is suspected, the following steps are recommended: 1) Fecal examination: direct smear, fecal flotation, and fecal culture to rule out parasitic and bacterial causes. For cats, PCR for Tritrichomonas foetus is recommended. 2) Baseline bloodwork: complete blood count (CBC), serum biochemistry profile, and urinalysis to assess systemic health and rule out metabolic diseases. 3) Abdominal imaging: radiographs to evaluate for foreign bodies, obstructions, or masses; abdominal ultrasound to assess the thickness of the rectal wall and surrounding tissues. 4) Colonoscopy: direct visualization of the rectal and colonic mucosa, allowing for biopsy. This is the gold standard for diagnosing IBD and neoplastic conditions. 5) Histopathology: biopsy samples should be taken from multiple sites, including the rectum, and evaluated by a pathologist. 6) Additional tests: if infectious causes are suspected, specific tests such as PCR for viral agents, fungal culture, or serology may be indicated. 7) In cases of suspected perianal fistula, examination under anesthesia and fistulography may be necessary. The diagnostic algorithm should be tailored to the individual patient based on clinical signs and initial findings.

Laboratory findings in proctitis are often non-specific but can provide supportive evidence. On CBC, there may be neutrophilia with a left shift in infectious cases, or eosinophilia in cases of parasitic or allergic proctitis. Anemia may be present due to chronic blood loss. Serum biochemistry may reveal hypoalbuminemia due to protein-losing enteropathy, and electrolyte imbalances (e.g., hypokalemia) due to diarrhea. In severe cases, elevated liver enzymes may be seen due to systemic inflammation. Urinalysis is usually unremarkable. Fecal analysis may show occult blood, mucus, and inflammatory cells. Fecal culture can identify bacterial pathogens, and PCR can detect viral or parasitic DNA. In cats, PCR for Tritrichomonas foetus is essential. Specific biomarkers such as C-reactive protein (CRP) may be elevated in inflammatory conditions. In cases of suspected hypothyroidism, thyroid hormone levels should be measured. Histopathology of rectal biopsies is the definitive diagnostic test, revealing the type and severity of inflammation.

Imaging plays a supportive role in the diagnosis of proctitis. Abdominal radiographs may show fecal impaction, foreign bodies, or masses in the pelvic canal. Contrast radiography (barium enema) can outline the rectal lumen and detect strictures or filling defects, but it is rarely used now due to the availability of endoscopy. Abdominal ultrasound is useful to assess the thickness of the rectal wall, which may be thickened in inflammatory or neoplastic conditions. It can also detect perirectal masses or abscesses. Doppler ultrasound can evaluate blood flow to the area. Computed tomography (CT) provides detailed cross-sectional images and is particularly helpful for staging neoplastic disease and evaluating the extent of perianal fistulas. Magnetic resonance imaging (MRI) offers superior soft tissue contrast and is valuable for assessing perianal fistulas and rectal masses. Endoscopy (colonoscopy) is the most important imaging modality, allowing direct visualization of the mucosa, assessment of erythema, ulceration, and masses, and collection of biopsy samples.

Cytology and histopathology are crucial for definitive diagnosis. Fine-needle aspiration (FNA) of rectal masses or thickened areas can be performed, but the yield is often low. Cytology of rectal scrapings or impression smears may reveal inflammatory cells, infectious organisms (e.g., Histoplasma), or neoplastic cells. Histopathology of biopsy samples is the gold standard. In lymphocytic-plasmacytic proctitis, there is infiltration of lymphocytes and plasma cells in the lamina propria. Eosinophilic proctitis shows a predominance of eosinophils. Granulomatous colitis, seen in Boxers, is characterized by macrophages containing periodic acid-Schiff (PAS)-positive material. Neoplastic conditions such as adenocarcinoma show malignant epithelial cells with glandular formation. Special stains (e.g., Gram stain, Giemsa, PAS) can help identify infectious agents. Histopathology also assesses the degree of fibrosis, ulceration, and architectural distortion, which are important for prognosis.

Treatment of proctitis depends on the underlying cause. For infectious proctitis, specific antimicrobial therapy is indicated. Bacterial infections are treated with appropriate antibiotics based on culture and sensitivity; empirical choices include metronidazole (10-15 mg/kg PO q12h) or tylosin (10-20 mg/kg PO q12h). Parasitic infections are treated with anthelmintics; for whipworms, fenbendazole (50 mg/kg PO q24h for 3 days) is effective. Tritrichomonas foetus in cats is treated with ronidazole (30 mg/kg PO q24h for 14 days), but it must be compounded and used with caution due to neurotoxicity. Fungal infections require systemic antifungals such as itraconazole (5-10 mg/kg PO q24h) or amphotericin B. For inflammatory bowel disease, immunosuppressive therapy is the mainstay. Prednisone (1-2 mg/kg PO q12h) is commonly used, with tapering over weeks to months. In refractory cases, additional immunosuppressants such as azathioprine (2 mg/kg PO q24h) or chlorambucil (0.1-0.2 mg/kg PO q24h) may be added. Dietary management is crucial; a highly digestible, low-residue diet or a novel protein/hydrolyzed protein diet is recommended. Fiber supplementation (e.g., psyllium) can help normalize fecal consistency. For perianal fistulas, medical therapy with cyclosporine (5 mg/kg PO q24h) and ketoconazole (10 mg/kg PO q24h) to increase cyclosporine levels is effective. Surgical intervention may be necessary for neoplastic masses, strictures, or severe fistulas. Supportive care includes fluid therapy for dehydration, antiemetics if vomiting, and analgesics for pain. In acute severe cases, hospitalization may be required.

The prognosis for proctitis varies depending on the etiology. Acute infectious proctitis generally has a good prognosis with appropriate antimicrobial therapy, though severe cases can be fatal if not treated promptly. Chronic inflammatory bowel disease has a guarded to good prognosis with long-term management, but relapses are common. Eosinophilic proctitis often responds well to dietary changes and corticosteroids. Granulomatous colitis in Boxers has a poor prognosis if not treated aggressively; early treatment with enrofloxacin (5-10 mg/kg PO q24h) has been shown to be effective in some cases. Neoplastic proctitis carries a poor to grave prognosis, depending on the tumor type and stage. Perianal fistulas have a good prognosis with cyclosporine therapy, but recurrence is possible. Negative prognostic indicators include severe weight loss, hypoalbuminemia, and lack of response to initial therapy. Regular monitoring and adjustment of treatment are essential for long-term control.

Follow-up for proctitis should be tailored to the underlying cause. For acute infectious cases, re-evaluation should occur within 1-2 weeks to assess response to therapy. Fecal examinations should be repeated to confirm clearance of parasites. For chronic IBD, patients should be re-evaluated every 2-4 weeks initially to monitor response to immunosuppressive therapy and adjust drug dosages. Serial bloodwork, including CBC and serum biochemistry, is recommended to monitor for drug side effects (e.g., bone marrow suppression with azathioprine). Fecal consistency and clinical signs should be monitored daily by the owner. Repeat colonoscopy with biopsy may be indicated if there is no improvement or if clinical signs worsen. For neoplastic conditions, imaging (ultrasound or CT) should be repeated every 3-6 months to monitor for metastasis. Long-term management may require lifelong medication and dietary restrictions. Owners should be educated on the importance of compliance and the potential for relapse.

Pearls: 1) Always perform a digital rectal examination in any dog or cat with tenesmus or hematochezia; it can reveal masses, strictures, or foreign bodies. 2) In young cats with chronic large-bowel diarrhea, test for Tritrichomonas foetus using PCR, as it is often misdiagnosed as IBD. 3) In Boxers with granulomatous colitis, early treatment with enrofloxacin can be curative; do not delay biopsy. 4) For perianal fistulas, cyclosporine is the treatment of choice; ketoconazole can be used to reduce the dose and cost. 5) Dietary management is key in IBD; a novel protein or hydrolyzed diet can significantly improve clinical signs. Pitfalls: 1) Do not use corticosteroids in infectious proctitis without appropriate antimicrobial therapy, as it can worsen the infection. 2) Avoid using metronidazole as a sole treatment for IBD; it has anti-inflammatory properties but is not as effective as corticosteroids. 3) Do not perform surgery for perianal fistulas without trying medical therapy first, as surgery can lead to complications. 4) Do not ignore the possibility of a foreign body; radiographs may not always show radiolucent objects. 5) Do not forget to recheck fecal samples after treatment for parasites, as reinfection is common.

Based on Plumb's Veterinary Drug Handbook, the following drug protocols are recommended for proctitis: 1) Metronidazole: 10-15 mg/kg PO q12h for 5-7 days for bacterial or protozoal infections; also used as an anti-inflammatory in IBD at 10-15 mg/kg PO q12h. 2) Tylosin: 10-20 mg/kg PO q12h for 7-10 days for bacterial colitis. 3) Fenbendazole: 50 mg/kg PO q24h for 3-5 days for whipworms. 4) Ronidazole: 30 mg/kg PO q24h for 14 days for Tritrichomonas foetus; must be compounded and used with caution; monitor for neurotoxicity. 5) Itraconazole: 5-10 mg/kg PO q24h for histoplasmosis; monitor liver enzymes. 6) Prednisone: 1-2 mg/kg PO q12h for IBD, tapering over 4-6 weeks to the lowest effective dose. 7) Azathioprine: 2 mg/kg PO q24h for refractory IBD; monitor CBC for myelosuppression. 8) Chlorambucil: 0.1-0.2 mg/kg PO q24h for cats with IBD. 9) Cyclosporine: 5 mg/kg PO q24h for perianal fistulas; can be combined with ketoconazole (10 mg/kg PO q24h) to increase blood levels. 10) Enrofloxacin: 5-10 mg/kg PO q24h for granulomatous colitis in Boxers. 11) Sulfasalazine: 20-30 mg/kg PO q8h for 3-4 weeks for colitis; use with caution in cats due to salicylate toxicity. 12) Budesonide: 2-3 mg/m² PO q24h for IBD in dogs; less systemic side effects. 13) Probiotics: may be beneficial as adjunctive therapy. Always adjust dosages for renal or hepatic impairment and monitor for drug interactions.

Evidence-based literature on proctitis in veterinary medicine is limited, but several studies and consensus guidelines provide guidance. The ACVIM consensus statement on inflammatory bowel disease in dogs and cats (2010) recommends a stepwise approach to diagnosis and treatment, emphasizing the importance of histopathology and dietary trials. Studies have shown that a combination of immunosuppressive therapy and dietary modification is effective in managing IBD. For granulomatous colitis in Boxers, a study by Mansfield et al. (2009) demonstrated that enrofloxacin is effective, likely due to its activity against adherent-invasive E. coli. For perianal fistulas, a randomized controlled trial by Mathews et al. (1997) showed that cyclosporine is superior to surgery. In cats, a study by Gookin et al. (2006) established the efficacy of ronidazole for Tritrichomonas foetus. Regarding infectious proctitis, antimicrobial therapy should be guided by culture and sensitivity, but empirical therapy with metronidazole is often used. The use of probiotics is supported by some studies, but evidence is not conclusive. Overall, a thorough diagnostic workup and individualized treatment plan are essential for successful management of proctitis.